Á¦¹Ì±Û·Î ÀçÈ°ÀÇÇаú°¡ ¼ÛâÈƳ»°úÀÇ¿ø ¿ÃÇØ ¼Ó»ç¶û ±¸Ãë °í¿îÇǺΰú ±Ë¾ç¼º ¹éÇ÷º´ ¹Ì·¡¼Ò¾Æû¼Ò³â°úÀÇ¿ø ´ÃǪ¸¥ÀÇ¿ø ¾Æ¸§´Ù¿îÇǺΰúÀÇ¿ø »ç¶ûÀÇ¿ä¾çº´¿ø Ǫ¸¥ÀÇ¿ø ¾Æ»êÅ°Áî¼Ò¾Æû¼Ò³â°úÀÇ¿øÃÖÀûÁöÀÎ ¿À´Â ¾Ë¾ÆµÎ´Â µ¿ÀǺ¸°¨º»ÇÑÀÇ¿ø ¾ç±Íºñ¼ö¼ú

Áúº´Á¤º¸
Á¦¸ñ

Äɳ׵ðº´(Kennedy Disease)

¥°.°³¿ä Äɳ׵𠺴(±¸Ã´¼ö¸¶ºñ ±ÙÀ§ÃàÁõ)Àº ¿îµ¿½Å°æ°ú °¨°¢½Å°æÀÇ ÅðÇ༺ º¯¼ºÀ» º¸ÀÌ´Â ÁúȯÀ¸·Î, ÇϺΠ¿îµ¿½Å°æ¼¼Æ÷ÀÇ ÅðÇàÀ¸·Î ÀÎÇØ ±ÙÀ§ºÎ ±ÙÀ°ÀÇ ±Ù·Â¾àÈ­ ¹× ±ÙÀ§ÃàÀ» ¾ß±âÇÏ°í

Ãßõ¼ö : 2 , Á¶È¸¼ö : 7,507 , ´ñ±Û¼ö : 0

±â²ÙÂ(Kikuchis disease)

¥°.°³¿ä ±â²ÙÂî º´Àº 1972³â ÀϺ»¿¡¼­ ±â²ÙÂî¿Í ÈÄÁö¸ðÅä µî¿¡ ÀÇÇؼ­ óÀ½ º¸°íµÈ ÁúȯÀ¸·Î, µ¿¾ç¿¡¼­ ÈçÇÏ°í ¼­¾ç¿¡¼­´Â µå¹°¸ç, ¿øÀÎÀ» ¾Ë ¼ö ¾øÁö¸¸ ½Ã°£ÀÌ Áö³ª¸é ´ëºÎºÐ Àú

Ãßõ¼ö : 1 , Á¶È¸¼ö : 4,627 , ´ñ±Û¼ö : 0

Å×À̻轺º´(Tay-Sachs disease)

ÁÖ¿äÁúȯÁ¤º¸ °ü·ÃÁúȯ¸í : GM2 °­±Û¸®¿À»çÀ̵åÁß ¿µÇâºÎÀ§ : ü³»:°£,³ú,ºñÀå,Æó / ü¿Ü:±ÙÀ°,´« Áõ»ó : °£ºñÀåºñ´ë, ±Ù±äÀåÀÌ»ó, ¿îµ¿ ½ÇÁ¶Áõ, ´ëµÎÁõ, ¹ß´ÞÀå¾Ö

Ãßõ¼ö : 0 , Á¶È¸¼ö : 3,927 , ´ñ±Û¼ö : 0

ÄÚÃ÷º´(Coats disease)

ÁúȯÁÖ¿äÁ¤º¸ °ü·ÃÁúȯ¸í : »ïÃ⼺ ¸Á¸·º´Áõ(Exudative retinopathy), ¸Á¸· ¸ð¼¼Ç÷°üÈ®ÀåÁõ(Retinal telangiectasis) ¿µÇâºÎÀ§ : ü¿ÜÀÇ ´«

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,800 , ´ñ±Û¼ö : 0

Ä«³ª¹Ýº´(Canavan disease)

ÁÖ¿äÁúȯÁ¤º¸ °ü·ÃÁúȯ¸í : ASPA°áÇÌÁõ,aspartoacylase°áÇÌÁõ,ACY2°áÇÌÁõ,aminoacylase-2°áÇÌÁõ,ASP°ÝÇÌÁõ,Ä«³ª¹Ý ¹é»öÁúÀå¾Ö,Canavan-Van

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,681 , ´ñ±Û¼ö : 0

¿À½º±Â-½¶·¹ÅÍ(Osgood-Schlatter disease)

¥°.°³¿ä ¿À½º±Â-½¶·¹Åͺ´Àº ¿îµ¿½Ã ½½°³°ÇÀÇ °©ÀÛ½º·± ȤÀº Áö¼ÓÀûÀÎ °ßÀÎÀ¸·Î, Çô¸ð¾çÀÇ °æ°ñ °áÀý °ñ´ÜÀÌ ºÎºÐÀûÀ¸·Î ºÐ¸®µÈ °ÍÀ» ¸»ÇÏ¸ç ¼ºÀåÀÌ ¿Õ¼ºÇÑ Ã»¼Ò³â ½Ã±â¿¡ ºñ±³Àû ÈçÈ÷

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,416 , ´ñ±Û¼ö : 0

Æи®-·Ò¹ö±× ÁõÈıº(Parry-Romberg disease)

°ü·ÃÁúȯ¸í : ÁøÇ༺ ¹Ý¾ó±¼ À§Ãà(Progressive Hemifacial Atrophy : HFA), Æ丮-·Ò¹ö±× ÁõÈıº(PRS), ÁøÇ༺ ¾ó±¼¹Ý À§Ãà(Progressive

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,352 , ´ñ±Û¼ö : 0

ÇȺ´(Pick disease)

¥°.°³¿ä ÇȺ´(Pick's disease)Àº ºñ±³Àû µå¹® ½Å°æÅðÇ༺ ÁúȯÀ¸·Î¼­ ³úÀÇ ½Å°æ¼¼Æ÷ÀÇ ÁøÇ༺ Æı«¸¦ º¸ÀÌ´Â ÁúȯÀÔ´Ï´Ù. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î Áø´ÜµÈ Ä¡¸Å ȯÀÚ¿¡¼­ 1~2%

Ãßõ¼ö : 0 , Á¶È¸¼ö : 2,140 , ´ñ±Û¼ö : 0

°í½¦º´(Gaucher disease)

ÁúȯÁÖ¿äÁ¤º¸ °ü·ÃÁúȯ¸í : °í¼¼ º´ ¶Ç´Â °í¼Å º´ Á¦1Çü ½ºÇΰíÁöÁúÁõ,±Û·çÄÚ¼¼·¹ºê·Î½Ãµ¥À̽º °áÇÌÁõ,±Û·çÄڽǼ¼¶ó¸¶À̵¥À̽º °áÇÌÁõ,¼¼·¹ºê·Î½Ãµå¼º ÁöÁúÁõ ÁõÈıº,°í¼Å ºñÀåºñ´ë,±Û

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,894 , ´ñ±Û¼ö : 0

³ë¸®º´(Norrie disease)

°ü·ÃÁúȯ¸í : ¾Èº¯ µÎ°æºÎ ±Ù±äÀåÀÌ»ó (Cranio-cervical dystonia) Ư¹ß¼º ±¸°­-¾È¸é ±Ù±äÀåÀÌ»ó (Idiopathic oro-facial dystonia

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,791 , ´ñ±Û¼ö : 0

Àª½¼º´(Wilson disease)

¥°.°³¿ä Àª½¼º´(Wilson's disease ¶Ç´Â hepatolenticular degeneration)Àº ±¸¸®´ë»çÀÇ ÀÌ»óÀ¸·Î ÀÎÇØ ÁÖ·Î °£°ú ³úÀÇ ±âÀúÇÙ¿¡ °ú´ÙÇÑ ¾çÀÇ ±¸¸®

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,770 , ´ñ±Û¼ö : 0

ÀϽºº´(Eales disease)

¥°.°³¿ä ÀϽºº´Àº Henry Eales°¡ 1880³â ±â¼úÇÑ º´À¸·Î, ºñÃâÇ÷, º¯ºñ¸¦ µ¿¹ÝÇÑ ¹Ýº¹¼º À¯¸®Ã¼ÃâÇ÷À» Ư¡À¸·Î ÇÕ´Ï´Ù. Àεµ, Áßµ¿µî¿¡¼­ °¡Àå ÈçÇÑ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ°í

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,664 , ´ñ±Û¼ö : 0

»÷µåÈ£ÇÁº´(Sandhoff disease)

ÁÖ¿äÁúȯÁ¤º¸ °ü·ÃÁúȯ¸í : GM2 °­±Û¸®¿À»çÀ̵å Á¦ 2Çü,°­±Û¸®¿À»çÀÌµå º£Å¸ Çí¼Ò»ç¹Ì´Ïµ¥À̽º B°áÇÌÁõ,°­±Û¸®¿À»çÀ̵å GM2 Á¦2 À¯Çü,Çí¼Ò»ç¹Ì´Ïµ¥À̽ºA,B°áÇÌÁõ ¿µÇâºÎÀ§

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,659 , ´ñ±Û¼ö : 0

½Å ÀÌÇü¼ºÁõ(Obstructive cystic disease)

°ü·ÃÁúȯ¸í : Á¦ 2Çü ³¶¼º ½ÅÁúȯ (Renal Cystic Disease Type 2) ´Ù³¶¼º ½Å ÀÌÇü¼ºÁõ (Multicystic renal dysplasia) Á¦ 4

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,537 , ´ñ±Û¼ö : 0

¸®ºê¸¸-»è½ºº´(Libman-Sacks disease)

¥°.°³¿ä ¸®ºê¸¸-»è½ºº´Àº Àü½ÅÈ«¹Ý·çǪ½º ȯÀÚ Áß ¾à 10%¿¡¼­ ³ªÅ¸³ª´Â ½ÉÁúȯÀ¸·Î, ½ÉÀå ÆǸ·ÀÇ °æÈ­, ÆǸ· ¿ª·ù ¹× ÆǸ·ÀÌ µÎ²¨¿öÁö´Â Çö»óÀ» º¸ÀÌ´Â º´ÀÔ´Ï´Ù. ¸¹Àº °æ¿ì °æ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,413 , ´ñ±Û¼ö : 0

·¹ÇÁ¼¶º´(Refsums disease)

°ü·ÃÁúȯ¸í : Refsums disease, classic, Phytanic acid oxidase deficiecy, Heredopathia atactica polyneur

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,398 , ´ñ±Û¼ö : 0

´Ï¸¸-ÇÇÅ©º´(Niemann-Pick Disease)

ÁúȯÁÖ¿äÁ¤º¸ °ü·ÃÁúȯ¸í : ´Ï¸¸-ÇÈ º´,½ºÇΰíÁöÁúÁõ,ÁöÁú Á¶Á÷±¸Áõ,½ºÇÎ°í¸¶ÀÌ¿¤¸°ÁöÁúÁõ,½ºÇÎ°í¸¶ÀÌ¿¤¸° °áÇÌÁõ,¿¬¼ÒÀÚÇü ÀÌ»ó±äÀå ÁöÁúÁõ,DAF Sydrome,Nieman Pic

Ãßõ¼ö : 1 , Á¶È¸¼ö : 1,356 , ´ñ±Û¼ö : 0

ÄíÇÁ½ºº´(Kufs disease)

¥°.°³¿ä ÄíÇÁ½º º´Àº ¶óÀÌÆ÷Ǫ½Å (lipofuscin)À̶ó´Â ¹°ÁúÀÌ Ã¼³»¿¡ ÃàÀûµÇ´Â ÁúȯÀÔ´Ï´Ù. ÄíÇÁ½º º´Àº neuronal ceroid-lipofuscinosis (NCL)

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,244 , ´ñ±Û¼ö : 0

I-¼¼Æ÷º´(Æ÷ÇÔ¼¼Æ÷º´)(Inclusion Cell Disease)

ÁúȯÁÖ¿äÁ¤º¸ °ü·ÃÁúȯ¸í : Æ÷ÇÔ¼¼Æ÷º´(Inclusion Cell Disease), ·¹·ÎÀ̺´(Leroy Disease), ¹ÂÄÚ¸®ÇÇµå º´ IIÇü(ML Disorder, Tyle

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,176 , ´ñ±Û¼ö : 0

źÁö¿¡¸£º´(Tangier disease)

ÁúȯÁÖ¿äÁ¤º¸ °ü·ÃÁúȯ¸í : Á¦1Çü °í¹ÐµµÁö´Ü¹é°áÇÌÁõ(High density lipoprotein deficiency, tyle1), źÁö¿¡¸£Çü °í¹ÐµµÁö´Ü¹é°áÇÌÁõ(High

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,124 , ´ñ±Û¼ö : 0